HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Progestins activate vascular endothelial growth factor gene transcription in endometrial adenocarcinoma cells.

AbstractOBJECTIVE:
To determine whether progestins activate vascular endothelial growth factor (VEGF) gene transcription in endometrial adenocarcinoma cells.
DESIGN:
In vitro study.
SETTING:
University reproductive biology laboratories.
PATIENT(S):
None.
INTERVENTION(S):
Ishikawa cells were transfected with VEGF promoter-luciferase reporter constructs and expression vectors encoding human progesterone receptors (hPR) A or B. The cells were treated with different progestins and antiprogestins, and luciferase activity was compared with controls.
MAIN OUTCOME MEASURE(S):
Three functional progesterone response elements (PREs) in the VEGF promoter were identified by electrophoretic mobility-shift assay, and different constructs were created to assess each PRE.
RESULT(S):
In cells expressing hPRA or B, treatment with 10 nM R5020 or 100 nM medroxyprogesterone acetate statistically significantly increased luciferase activity (3.3- to 4.8-fold). Pretreatment with 100 nM RU486 blunted the effect of 10 nM R5020, resulting only in a slight, statistically nonsignificant increase in luciferase activity (1.3- to 1.7-fold). Although three different functional PREs could be identified, no single PRE accounted for the preponderance of the luciferase activity. Full VEGF promoter activation required all three PREs.
CONCLUSION(S):
Progestins have a direct effect on VEGF gene transcription. However, hPR-mediated transcriptional regulation of the VEGF promoter is complex and cannot be localized to confined PRE sequences. Other response element motifs are likely to play a contributory role.
AuthorsMichael D Mueller, Jean Louis Vigne, Elizabeth A Pritts, Victor Chao, Ekkehard Dreher, Robert N Taylor
JournalFertility and sterility (Fertil Steril) Vol. 79 Issue 2 Pg. 386-92 (Feb 2003) ISSN: 0015-0282 [Print] United States
PMID12568850 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Endothelial Growth Factors
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • Receptors, Progesterone
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • Mifepristone
  • Promegestone
  • Medroxyprogesterone
Topics
  • Adenocarcinoma (genetics)
  • Endometrial Neoplasms (genetics)
  • Endothelial Growth Factors (genetics)
  • Female
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Humans
  • Intercellular Signaling Peptides and Proteins (genetics)
  • Lymphokines (genetics)
  • Medroxyprogesterone (pharmacology)
  • Mifepristone (pharmacology)
  • Promegestone (pharmacology)
  • Receptors, Progesterone (physiology)
  • Transcription, Genetic (drug effects)
  • Transfection
  • Tumor Cells, Cultured
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: